Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00258_DB01017_nanopub.RATGmNraLLblGdi0HNPZKTMZHyCUnclNdfIO0PZPA1u8s#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00258_DB01017 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00258_DB01017 label "DDI between Calcium Acetate and Minocycline - Calcium salts such as calcium acetate may decrease the serum concentration of tetracycline derivatives such as minocycline. In general, the coadministration of oral calcium salts and oral tetracycline derivatives should be avoided. Interactions may be able to be minimized by administering oral calcium preparations several hours before or after the dose of the oral tetracycline derivatives. Even with dose separation, therapy may still be compromised. Monitor for decreased therapeutic effect of oral tetracycline derivatives. [drugbank_resource:DB00258_DB01017]" assertion.
- drugbank_resource:DB00258_DB01017 identifier "drugbank_resource:DB00258_DB01017" assertion.
- drugbank_resource:DB00258_DB01017 title "DDI between Calcium Acetate and Minocycline - Calcium salts such as calcium acetate may decrease the serum concentration of tetracycline derivatives such as minocycline. In general, the coadministration of oral calcium salts and oral tetracycline derivatives should be avoided. Interactions may be able to be minimized by administering oral calcium preparations several hours before or after the dose of the oral tetracycline derivatives. Even with dose separation, therapy may still be compromised. Monitor for decreased therapeutic effect of oral tetracycline derivatives." assertion.
- drugbank:DB01017 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00258_DB01017 assertion.
- drugbank:DB00258 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00258_DB01017 assertion.